Simeon George, CEO of life sciences investor SR One, speaks to Unquote about raising its first-time fund, the ongoing importance of its relationship with GSK following its spin-out from the company, and the firm's deal pipeline.
Merged company will have combined revenues of around €8m in 2020, and employ over 50 staff.
Digitalisation and project life cycle management business intends to expand in DACH and Benelux
Fund invests in pre-series-A and series-A rounds to support the growth of startups operating across a large variety of sectors
In conjunction with the announcement, the firm has hired an investment team from TenX Health